Your browser doesn't support javascript.
loading
Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re-emergence of syphilis and HIV pre-exposure prophylaxis use.
Quee, Franke A; Slot, Ed; van Leeuwen, Ingeborg; Brands, Ralph; Franssen, Eric J F; Hogema, Boris M; Zaaijer, Hans L; van de Laar, Thijs J W.
Afiliación
  • Quee FA; Department of Donor Medicine Research, Sanquin Research, Amsterdam, The Netherlands.
  • Slot E; Department of Public and Occupational Health, Amsterdam UMC, Amsterdam, The Netherlands.
  • van Leeuwen I; Amsterdam Public Health (APH) Research Institute, Amsterdam UMC, Amsterdam, The Netherlands.
  • Brands R; Department of Medical Affairs, Sanquin Corporate Staff, Amsterdam, The Netherlands.
  • Franssen EJF; Department of Clinical Pharmacy, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • Hogema BM; Department of Clinical Pharmacy, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • Zaaijer HL; Department of Clinical Pharmacy, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • van de Laar TJW; Department of Donor Medicine Research, Sanquin Research, Amsterdam, The Netherlands.
Transfusion ; 2024 Jul 04.
Article en En | MEDLINE | ID: mdl-38963400
ABSTRACT

BACKGROUND:

Less discriminatory donor selection policies for men who have sex with men (MSM) may impact transfusion safety in terms of higher residual risks for known transfusion-transmitted infections (TTIs), increased vulnerability toward new TTIs that are also transmitted via sex, and HIV infections masked by pre-exposure prophylaxis (PrEP). STUDY DESIGN AND

METHODS:

TTI trends in Dutch donors were studied over a 13-year period (2011-2023), characterized by successive relaxations of MSM deferral criteria. Structured posttest counseling was performed to determine risk factors in TTI-positive donors. PrEP drug levels were measured in 9977 donations from male donors living in urban areas and in 67 donors with active or resolved syphilis.

RESULTS:

HIV incidence (from 5.8 to 1.5 per 1,000,000 donor years (DY)) and HBV incidence (from 12.4 to 4.5 per 1,000,000 DY) in Dutch donors decreased with less stringent MSM deferral criteria, while syphilis prevalence (from 26.4 to 44.1 per 100,000 new donors) and syphilis incidence (from 18.3 to 46.3 per 1,000,000 DY) increased over time. The proportion of MSM-related syphilis rose from 2% to 32% in new donors and from 12% to 27% in repeat donors. PrEP was detected in 2 of 9977 (0.02%) donations from male donors living in urban areas, and in 1 of 39 (2.6%) male donors with syphilis.

DISCUSSION:

To date, phasing out donor deferral for MSM had no significant impact on transfusion safety in the Netherlands. However, rising syphilis rates and (recent) PrEP use in the blood donor population, albeit rare, suggest an influx of donors with higher sexual risk profiles and requires intensified TTI surveillance in donors.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Transfusion Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Transfusion Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos